RxDoctor Payments DataLook up a doctor →

Mitul Kanzaria, MD

Interventional Cardiology · Sunnyside, WANPI 1639499023

Payments from drug & device makers

$15,231in general payments, 2019–2025

Across 588 payments — averaging $25.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Abiomed$2K
  • Abbott$2K
  • AstraZeneca$1K
  • Medtronic$886
  • Johnson & Johnson$720
  • plus $5K from 39 others
$2,015in research payments, 2019–2025

Across 17 payments — averaging $118.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim International GmbH$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$15,231 in reported general payments places this provider in the 70th percentile of 125 interventional cardiology providers in Washington.

See all interventional cardiology providers in Washington

Medicare billing

Part B allowed, 2024
$311,327
Medicare patients
667
Services billed
3,030

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Sunnyside

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →